Psoriasis and cardiovascular risk factors: a case-control study on inpatients comparing psoriasis to dermatitis

Jonathan Shapiro1, Arnon David Cohen, Dahlia Weitzman

  • 1Rabin Medical Center, Petah Tikva, Sackler School of Medicine, Tel Aviv University, Israel.

Insights

Psoriasis is linked to increased risks of diabetes, hypertension, and smoking. This study highlights the systemic impact of psoriasis inflammation on cardiovascular disease risk factors in hospitalized patients.

Area of Science:

  • Dermatology and Cardiovascular Medicine
  • Inflammatory Disease Mechanisms

Background:

  • Previous studies suggest a link between psoriasis and cardiovascular disease (CVD) risk factors.
  • Many prior studies relied on potentially inaccurate diagnostic codes from outpatient databases.

Purpose of the Study:

  • To investigate the association between psoriasis and cardiovascular disease risk factors.
  • To compare psoriatic inpatients with dermatitis inpatients regarding CVD risk factors.

Main Methods:

  • A case-control study involving 1079 psoriatic inpatients and 1079 matched dermatitis inpatients.
  • Utilized computerized medical databases to assess prevalence of smoking, obesity, diabetes, hypertension, hyperlipidemia, and CVD.
  • Employed multivariate logistic regression for analysis.

Main Results:

  • Psoriasis independently predicts higher odds of diabetes (OR 1.43), hypertension (OR 1.31), and smoking (OR 1.38).
  • Obesity showed a trend towards association (OR 1.32), but did not reach statistical significance.
  • No significant association was found between psoriasis and CVD after adjusting for diabetes, obesity, and hypertension.

Conclusions:

  • Psoriasis is an independent risk factor for several key cardiovascular disease risk factors.
  • The inflammatory nature of psoriasis may contribute to systemic effects leading to CVD risk.
  • Study limitations include an inpatient-only cohort, potentially overrepresenting severe cases.
Abstract

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...